MTHFR (methylenetetrahydrofolate reductase) C677T polymorphism and psoriasis

被引:0
|
作者
Vladimir Vasku
Julie Bienertova-Vasku
Miroslav Necas
Anna Vasku
机构
[1] Masaryk University Brno,1st Department of Dermatology, St. Ann’s Faculty Hospital
[2] Masaryk University,Department of Pathophysiology, Faculty of Medicine
来源
关键词
MTHFR; Polymorphism; Psoriasis; Folate; DNA methylation;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the study was to evaluate possible association of MTHFR C677T gene polymorphism (NM_005957) with psoriasis. Genotypes of MTHFR C677T gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. Case group (n = 410) included patients with psoriasis (plaque psoriasis diagnosed in 285 patients, other subtypes of psoriasis were observed in 125 patients). Control group (n = 244) consisted of healthy subjects without individual history of psoriasis, with similar age and gender characteristics. The MTHFR C677T polymorphism genotypes were determined by a polymerase chain reaction and a subsequent restriction analysis with HinfI. The genotypes of C(677)T methylenetetrahydrofolate reductase (MTHFR) gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. We proved a significant difference in genotype distribution (Pg = 0.03) and allelic frequency (Pa = 0.02) between psoriatic and control subjects (Table 3). The CC (the thermostabile) genotype was significantly more frequent in psoriatic patients compared to controls [OR = 1.55, 95% confidential interval (CI) = 1.12–2.15, P = 0.004814, Pcorr = 0.01]. But, a significant increase of T allele in MTHFR gene was observed in patients with positive family history of diabetes (Pa = 0.02) and in those with a frequent tonsillitis/tonsillectomy (Pa = 0.04). No difference was observed between patients with and without positive family history of psoriasis (Pa = 0.251). But, when psoriatic patients were described for FHDM, FH-Ps, and PH-T simultaneously, The highest incidence of CT + TT genotypes was calculated for psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy compared to patients without all these three phenotypes (odds ratio = 3.17, 95% CI 1.33–7.56, Pcorr = 0.04). In conclusion, MTHFR C677T polymorphism is marginally associated with psoriasis. The T allele (thermolabile) appears to be more frequent in psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy. This could reflect an inborn predisposition in complex regulation in one-carbon moieties transport in psoriatic patients and therefore, MTHFR genotype can be a part of genetic background of psoriasis.
引用
收藏
页码:327 / 331
页数:4
相关论文
共 50 条
  • [31] Methylenetetrahydrofolate reductase C677T polymorphism and diabetic retinopathy
    Joob, Beuy
    Wiwanitkit, Viroj
    OPHTHALMIC GENETICS, 2018, 39 (03) : 414 - 414
  • [32] Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Alzheimer Disease Risk: a Meta-Analysis
    Rai, Vandana
    MOLECULAR NEUROBIOLOGY, 2017, 54 (02) : 1173 - 1186
  • [33] Association between methylenetetrahydrofolate reductase C677T polymorphism and psoriasis: A meta-analysis
    Wu, Dongze
    Shi, Deshun
    Yang, Li
    Zhu, Xiaoliang
    JOURNAL OF DERMATOLOGY, 2016, 43 (02): : 162 - 169
  • [34] C677T gene polymorphism of methylenetetrahydrofolate reductase (MTHFR) in meningiomas and high-grade gliomas
    Kafadar, Ali Metin
    Yilmaz, Hulya
    Kafadar, Didem
    Ergen, Arzu
    Zeybek, Umit
    Bozkurt, Nilufer
    Kuday, Gengiz
    Isbir, Turgay
    ANTICANCER RESEARCH, 2006, 26 (3B) : 2445 - 2449
  • [35] Association of methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism with autism: evidence of genetic susceptibility
    Rai, Vandana
    METABOLIC BRAIN DISEASE, 2016, 31 (04) : 727 - 735
  • [36] Risk of invasive cervical cancer is decreased with a common (C677T) methylenetetrahydrofolate reductase (MTHFR) polymorphism
    Weinstein, SJ
    McGlynn, KA
    Ziegler, RG
    FASEB JOURNAL, 2000, 14 (04): : A36 - A36
  • [37] Methylenetetrahydrofolate reductase polymorphism (MTHFR C677T) and bone mineral density in Chinese men and women
    Li, M
    Lau, EMC
    Woo, J
    BONE, 2004, 35 (06) : 1369 - 1374
  • [38] The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures
    Shiraki, Masataka
    Urano, Tomohiko
    Kuroda, Tatsuhiko
    Saito, Mitsuru
    Tanaka, Shiro
    Miyao-Koshizuka, Mariko
    Inoue, Satoshi
    JOURNAL OF BONE AND MINERAL METABOLISM, 2008, 26 (06) : 595 - 602
  • [39] Risk of colorectal cancer associated with the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the Kashmiri population
    Sameer, A. S.
    Shah, Z. A.
    Nissar, S.
    Mudassar, S.
    Siddiqi, M. A.
    GENETICS AND MOLECULAR RESEARCH, 2011, 10 (02): : 1200 - 1210
  • [40] Interaction of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and folic acid levels in recurrent depression
    Lok, A.
    Assies, J.
    Koeter, M. W.
    Bockting, C. L.
    Visser, I.
    Moeton, M.
    JOURNAL OF AFFECTIVE DISORDERS, 2008, 107 : S75 - S75